Neurol. praxi. 2009;10(4):213-215

Histopathology of spinal and spinal cord tumours

MUDr. Boris Rychlý
CYTOPATHOS spol. s. r. o., bioptické, cytologické a skríningové laboratórium, Bratislava

Like brain tumours, spinal and spinal cord tumours exhibit a broad histogenetic diversity. They can originate in any anatomical structure in

this region. They arise from the spinal cord itself, the spinal roots, the dural sac, or the adjacent hard (bone) or soft tissues. The tumours are

topographically classified into extradural and intradural ones that are subdivided into extramedullary and intramedullary. Histologically,

they are identical to brain tumours with the same principles of grading. However, their incidence mostly differs from that of identical tumours

in the brain. They may be either primary or secondary ones in the form of metastases from virtually any other location in the body.

Keywords: spinal tumours, histopathology.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rychlý B. Histopathology of spinal and spinal cord tumours. Neurol. praxi. 2009;10(4):213-215.
Download citation

References

  1. Alvisi C, Cerisoli M, Giulioni M. Intramedullary spinal gliomas: Long-term results of surgical treatments. Acta Neurochirurgica 1984; 70: 169-179. Go to original source... Go to PubMed...
  2. Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000; 1: 71-76. Go to original source... Go to PubMed...
  3. Brat D, Giannini C, Scheithauer B, Burger P. Primary Melanocytic Neoplasms of the Central Nervous System. American Journal of Surgical Pathology 1999; 7: 745-754. Go to original source... Go to PubMed...
  4. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A. Ki67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 2007; 27: 114-120. Go to original source... Go to PubMed...
  5. Cushing H, Eisenhardt L. Meningiomas, their classification, regional behaviour, life history, and end surgical results. Springfield, Charles C Thomas, 1938: 42-47. Go to original source...
  6. Delauche-Cavallier M, Laredo J, Wibier M, Bard M, Mazabraudt A, Darne J, Kuntz D, Ryckewaert A. Solitary Plasmocytoma of the Spine: Long-Term Clinical Course. Cancer. 1988; 61: 1707-1714. Go to original source...
  7. DeMonte F, Gilbert M, Mahajan A. Tumors of the Brain and Spine. Springer 2007: 326. Go to original source...
  8. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 2006; 48: 63-74. Go to original source... Go to PubMed...
  9. Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO Classification of Tumours of the Central Nervous System, World Health Organization, 4 edition, 2007: 164-172.
  10. Vankalakunti M, Vasishta R, Radotra B, Khosla V. MIB1 immunolabeling: A valuable marker in prediction of benign recurring meningiomas. Neuropathology 2007; 27: 407-412. Go to original source... Go to PubMed...
  11. York J, Kaczaraj A, Abi-Said D, Fuller G, Skibber J, Janjan N, Gokaslan Z. Sacral Chordoma: 40-Year Experience at a Major Cancer Center. Neurosurgery 1999; 1: 74-79. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.